Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference
Globe Newswire•27/08/2026•09:05 ET
0
Whiz Insights
SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces Myriad management will present at the 21(st) Annual Wells Fargo Healthcare Conference in Boston on Thursday, September 10, 2026 at 11:00am EST.
The presentation will be available through a live audio webcast link in the investor information section of Myriad’s website at investor.myriad.com.
Get started
Create a free account to read the full story.